By Lisa Schnirring, June 14, 2024 Though the US Food and Drug Administration (FDA) last week recommended that vaccine companies switch to the JN.1 variant for updated shots for the fall, yesterday it urged companies to focus on the KP.2 lineage if …
COVID patients at higher risk for respiratory complications well after infection, study finds
By Mary Van Beusekom, MS, The University of Minnesota, May 28, 2024 The risks of respiratory complications were eightfold and nearly twofold greater in COVID-19 patients in South Korea and Japan during and after infection, respectively, than in the general population, …